Optimal PCI London 2023
Published: 13 October 2023
-
Views:
3766 -
Likes:
7
-
Views:
3766 -
Likes:
7
-
12m 29sPart 4 | Session 1 Too tough to treat – the high-risk landscape
-
21m 23sPart 4 | Session 2 Mapping the path: hemodynamics to delineate risk and define strategy
-
11m 57sPart 4 | Session 3 Crossing the crucible: strategies for high-risk CTO PCI in LV dysfunction
-
5m 11sPart 4 | Session 4 What we learned and should look for in the interactive session
-
4m 6sPart 1 | Session 1 Welcome and introduction James Spratt
-
13m 47sPart 1 | Session 2 Less time, less money, more complexity Allen Jeremias
-
26m 49sPart 1 | Session 3 Point and shoot? Planning fundamentals Natalia Pinilla
-
15m 12sPart 1 | Session 4 Confusion or clarity? How to negotiate the information matrix Carlos Collet
-
44m 1sPart 1 | Session 5 Live case 1: Hospital Clínic de Barcelona (Spain) / Live case 2: Hartcentrum OLV Aalst (Belgium) Salvatore Brugaletta, Manel Sabaté, Jeroen Sonck, Adriaan Wilgenhof
-
7m 28sPart 1 | Session 6 What we learned and should look for in the interactive session Frédéric Bouisset
-
13m 57sPart 2 | Session 1 Calcium – it’s all sorted? Margaret McEntegart
-
27m 35sPart 2 | Session 2 Gone, but not forgotten – Calcified nodules Ziad A Ali
-
10m 3sPart 2 | Session 3 Calcium in special scenarios Simon Wilson
-
1h 6m 45sPart 2 | Session 4 Live case 3: St George’s Hospital, London (UK) / Live case 4: Hospital Clinico San Carlos, Madrid (Spain) James Spratt, Richard A Shlofmitz, Javier Escaned, Nieves Gonzalo
-
4m 56sPart 2 | Session 5 What we learned and should look for in the interactive session Novalia Sidik
-
4m 53sPart 3 | Session 1 Welcome and recap Ziad A Ali
-
4m 28sPart 3 | Session 2 My stents last forever, why should I listen? Angela McInerney
-
10m 38sPart 3 | Session 3 Doom loop, or durable solution, how can I navigate? Evan Shlofmitz
-
40m 24sPart 3 | Session 4 Algorithmic ISR treatment: what could go wrong? Kevin Croce
Overview
Radcliffe are delighted to partner with Optima Education to host the on-demand Optimal PCI London 2023 event.
Optimal PCI London 2023 was a hybrid two-day event held on the 2–3 October at The Royal College of Physicians, London, UK. With over 20 expert faculty, it focused on six complex, high-risk intervention topics: pre-procedural planning, imaging, calcium, stent failure, left main PCI and CTO / LV support.
Optima is proud to partner with OPCI (NYC), to bring you the next instalment in leading cardiology education.
At Optima, we believe that education is central to patient care. Our unique approach is designed to help you develop the thinking, skills and knowledge to optimise patient care. We clarify and simplify clinical messaging into engaging and accessible content. Our values of quality, simplicity and innovation are central to this vision.
Optima would like to thank the following sponsors:
Lead: Shockwave Medical, Boston Scientific and Abbott
Supporting: ASAHI INTECC, Teleflex, Vascular Perspectives, HeartFlow, Medtronic, CathWorks, Cordis, Abiomed, Philips, GE Healthcare, Seigla Medical, RAMPART, HCA Healthcare and CoreAalst
Learning Objectives
- Understand the main elements in pre-procedural planning and how it guides PCI
- Explore the role of coronary arterial calcium in driving adverse outcomes, how to assess and treat these patients safely
- Understand what causes stent failure, how this is assessed and what drives treatment options in each case
- Explore the role of left ventricular support in complex coronary artery disease
Target Audience
- Interventional Cardiologists
- Interventional Cardiology Nurses
- Cathlab Personnel
- Interventional Fellows
More from this programme
Part 1
Day 1, Session 1: Pre-procedure planning – are we lost without a map?
Part 2
Day 1, Session 2: Coronary calcium – too hard to crack?
Part 3
Day 2, Session 3: Stent failure – can we ignore this?
Part 4
Day 2, Session 4: High-risk and complex – too tough to treat?
Faculty Biographies
Margaret B McEntegart
Director of Complex PCI and CTO Programmes
Dr Margaret McEntegart serves as the Director of Complex PCI and CTO programmes at Columbia University Irving Medical Center, New York, US. She also holds the role of Director of Cardiac Catheterization Laboratories at Columbia University Irving Medical Center / New York-Presbyterian Hospital.
Before joining Columbia, Dr McEntegart served as a consultant interventional cardiologist at Golden Jubilee National Hospital (UK), where she played a pivotal role in establishing and leading the CTO and Complex PCI Programme.
Simon Wilson
Interventional Cardiologist
Dr Simon Wilson is an Interventional Cardiologist at St George's Hospital, London UK.
Dr Wilson is dedicated to improving patient safety and outcomes and in 2021, was appointed the head of governance for cardiology at St George’s. His main focus is to help understand the cause of symptoms and deliver evidence-based treatment to improve quality of life and minimise the risk of future cardiac events.
He is currently the principal or co-investigator for several national and international studies with a focus on improving outcomes in patients with coronary artery disease.
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Comments